Abstract
Background Schizophrenia is associated with aberrant gamma band power, hypothesized to reflect imbalance in the excitation-inhibition (E/I) ratio and undermine neural signal efficiency. Relationships between resting-state gamma, E/I balance, and regional hemodynamics from the fMRI BOLD signal are unknown.
Methods We recorded simultaneous EEG-fMRI at rest, with eyes open, in people with schizophrenia (n= 57) and people without a psychiatric diagnosis (n= 46) and identified gamma and aperiodic EEG parameters associated with E/I balance. Measures from all EEG channels were entered into a whole-brain, parametric modulation analysis followed by statistical correction for multiple comparisons. Sensory gating was assessed using the Sensory Gating Inventory, and psychotic symptoms were assessed using the Positive and Negative Syndrome Scale.
Results Across groups, gamma power modestly predicts a steeper aperiodic slope (greater inhibition), without group differences in either gamma power or aperiodic slope. In schizophrenia, gamma-BOLD coupling was reduced in bilateral auditory regions of the superior temporal gyri and inversely correlated with sensory gating deficits and symptom severity. Analysis of the spectral features of scanner sounds revealed distinct peaks in the gamma range, reflecting a rapidly repeating scanner pulse sound present throughout the resting state recording.
Conclusion Regional hemodynamic support for putative inhibitory and excitatory contributions to resting EEG are aberrant in SZ. Deficient gamma coupling to auditory BOLD may reflect impaired gating of fMRI-scanner sound.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from National Institute of Mental Health (R01MH058262-17 to JMF) and the VA (I01CX000497-06 to JMF, IK1CX002089 to MSJ). DHM consults for Boehringer Ingelheim. The authors have declared that there are no conflicts of interest in relation to the subject of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study procedures were approved by the University of California at San Francisco and the San Francisco Veterans Affairs Medical Center Institutional Review Boards (FWA #00000068).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: Michael.Jacob{at}ucsf.edu
kaiasargent7{at}gmail.com
Brian.Roach{at}ncire.org
elhum.shamshiri{at}ucsf.edu
Daniel.Mathalon{at}ucsf.edu
Judith.Ford{at}ucsf.edu
Data Availability
Data and code are available from the authors upon reasonable request. Our informed consent procedure specified that de-identified data may be shared with collaborators. Our institutional policy requires that collaborators enter into a formal data sharing agreement with the San Francisco Veterans Affairs Health Care System.
